Sitryx Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel oral therapies to restore immune balance in autoimmune and inflammatory diseases
Sitryx Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel oral therapies to restore immune balance in autoimmune and inflammatory diseases. The company has a robust pipeline of drug candidates, including GLS1 inhibitors and PKM2 modulators, aimed at addressing unmet medical needs in immunometabolism.